Income Statement (TTM)
Glenmark Pharmaceuticals Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 107,445 | 107,778 | 109,439 | 116,144 | 118,248 | 122,103 | 123,049 | 121,173 | 123,451 | 126,355 | 116,556 | 136,144 | 137,510 | 131,575 | 126,454 | 128,612 | 130,799 | 139,960 | 133,633 | 134,557 |
| Change (%) | 0.31 | 1.54 | 6.13 | 1.81 | 3.26 | 0.78 | -1.52 | 1.88 | 2.35 | -7.76 | 16.81 | 1.00 | -4.32 | -3.89 | 1.71 | 1.70 | 7.00 | -4.52 | 0.69 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 39,016 | 38,866 | 38,470 | 40,294 | 42,804 | 44,409 | 45,481 | 42,584 | 44,444 | 45,385 | 44,108 | 47,529 | 50,731 | 50,389 | 45,789 | 43,357 | 43,735 | 44,255 | 45,250 | 42,588 |
| Change (%) | -0.38 | -1.02 | 4.74 | 6.23 | 3.75 | 2.41 | -6.37 | 4.37 | 2.12 | -2.81 | 7.76 | 6.74 | -0.67 | -9.13 | -5.31 | 0.87 | 1.19 | 2.25 | -5.88 | |
| % of Revenue | 36.31 | 36.06 | 35.15 | 34.69 | 36.20 | 36.37 | 36.96 | 35.14 | 36.00 | 35.92 | 37.84 | 34.91 | 36.89 | 38.30 | 36.21 | 33.71 | 33.44 | 31.62 | 33.86 | 31.65 |
| Gross Operating Profit | 68,429 | 68,912 | 70,970 | 75,850 | 75,444 | 77,693 | 77,568 | 78,589 | 79,007 | 80,970 | 72,448 | 88,615 | 86,779 | 81,186 | 80,665 | 85,256 | 87,064 | 95,705 | 88,383 | 91,969 |
| Change (%) | 0.71 | 2.99 | 6.88 | -0.53 | 2.98 | -0.16 | 1.32 | 0.53 | 2.48 | -10.53 | 22.32 | -2.07 | -6.44 | -0.64 | 5.69 | 2.12 | 9.92 | -7.65 | 4.06 | |
| % of Revenue | 63.69 | 63.94 | 64.85 | 65.31 | 63.80 | 63.63 | 63.04 | 64.86 | 64.00 | 64.08 | 62.16 | 65.09 | 63.11 | 61.70 | 63.79 | 66.29 | 66.56 | 68.38 | 66.14 | 68.35 |
| SG&A | 28,992 | 29,386 | 28,103 | 24,305 | 28,841 | 28,735 | 29,176 | 24,874 | 30,013 | 31,713 | 31,833 | 28,740 | 34,998 | 35,454 | 34,465 | 28,973 | 35,523 | 35,877 | 36,814 | 30,744 |
| Change (%) | 1.36 | -4.37 | -13.51 | 18.66 | -0.37 | 1.54 | -14.75 | 20.66 | 5.66 | 0.38 | -9.72 | 21.78 | 1.30 | -2.79 | -15.93 | 22.61 | 1.00 | 2.61 | -16.49 | |
| % of Revenue | 26.98 | 27.27 | 25.68 | 20.93 | 24.39 | 23.53 | 23.71 | 20.53 | 24.31 | 25.10 | 27.31 | 21.11 | 25.45 | 26.95 | 27.25 | 22.53 | 27.16 | 25.63 | 27.55 | 22.85 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 93,121 | 92,825 | 92,279 | 98,275 | 99,291 | 101,564 | 104,649 | 104,594 | 106,818 | 110,885 | 105,174 | 117,556 | 119,482 | 120,330 | 111,997 | 112,327 | 112,983 | 113,459 | 114,564 | 114,964 |
| Change (%) | -0.32 | -0.59 | 6.50 | 1.03 | 2.29 | 3.04 | -0.05 | 2.13 | 3.81 | -5.15 | 11.77 | 1.64 | 0.71 | -6.92 | 0.29 | 0.58 | 0.42 | 0.97 | 0.35 | |
| % of Revenue | 86.67 | 86.13 | 84.32 | 84.62 | 83.97 | 83.18 | 85.05 | 86.32 | 86.53 | 87.76 | 90.24 | 86.35 | 86.89 | 91.45 | 88.57 | 87.34 | 86.38 | 81.07 | 85.73 | 85.44 |
| Operating Income | 14,324 | 14,953 | 17,160 | 17,868 | 18,957 | 20,539 | 18,400 | 16,579 | 16,633 | 15,470 | 11,382 | 18,588 | 18,028 | 11,246 | 14,457 | 16,285 | 17,816 | 26,501 | 19,069 | 19,593 |
| Change (%) | 4.39 | 14.76 | 4.13 | 6.09 | 8.34 | -10.41 | -9.90 | 0.32 | -6.99 | -26.43 | 63.32 | -3.01 | -37.62 | 28.55 | 12.65 | 9.40 | 48.74 | -28.04 | 2.74 | |
| % of Revenue | 13.33 | 13.87 | 15.68 | 15.38 | 16.03 | 16.82 | 14.95 | 13.68 | 13.47 | 12.24 | 9.76 | 13.65 | 13.11 | 8.55 | 11.43 | 12.66 | 13.62 | 18.93 | 14.27 | 14.56 |
| Interest Expense | -3,689 | -3,683 | -3,531 | -3,350 | -3,233 | -2,946 | -2,981 | -2,825 | -2,966 | -3,272 | -3,490 | -4,016 | -4,399 | -4,771 | -5,160 | -4,439 | -3,710 | -2,889 | -2,071 | -2,257 |
| Change (%) | -0.18 | -4.11 | -5.14 | -3.49 | -8.88 | 1.20 | -5.24 | 5.00 | 10.31 | 6.68 | 15.06 | 9.53 | 8.47 | 8.15 | -13.96 | -16.44 | -22.12 | -28.33 | 9.00 | |
| % of Revenue | -3.43 | -3.42 | -3.23 | -2.88 | -2.73 | -2.41 | -2.42 | -2.33 | -2.40 | -2.59 | -2.99 | -2.95 | -3.20 | -3.63 | -4.08 | -3.45 | -2.84 | -2.06 | -1.55 | -1.68 |
| Net Income | 8,992 | 9,565 | 9,700 | 10,226 | 10,464 | 10,202 | 9,417 | 8,277 | 8,305 | 8,811 | 2,972 | 2,546 | -877 | -7,117 | -15,017 | -13,113 | -8,752 | -1,758 | 10,471 | 7,537 |
| Change (%) | 6.38 | 1.41 | 5.42 | 2.33 | -2.50 | -7.69 | -12.11 | 0.34 | 6.10 | -66.27 | -14.33 | -134.45 | 711.17 | 111.00 | -12.67 | -33.26 | -79.91 | -695.50 | -28.02 | |
| % of Revenue | 8.37 | 8.87 | 8.86 | 8.80 | 8.85 | 8.36 | 7.65 | 6.83 | 6.73 | 6.97 | 2.55 | 1.87 | -0.64 | -5.41 | -11.88 | -10.20 | -6.69 | -1.26 | 7.84 | 5.60 |
Source: Capital IQ
